Vision Systems Design
For drug formulation, development, manufacturing and shelf stability, the type, size and quantity of particulate matter present in injectable drugs affects the drug’s efficacy. In some cases, such non-soluble particles may also present a potential safety risk. Understanding the nature of these particles is critical to ensuring the drug products work as intended and do so without causing adverse events.
“Until recently, even the most advanced technology available had trouble detecting and counting particles smaller than 10 microns,” says Kent Peterson, CEO, Fluid Imaging Technologies (Scarborough, ME, USA; www.fluidimaging.com). “Lacking the technological ability to do so, it becomes easier to understand why many pharmaceutical scientists drew the line of concern at 10 microns and larger.” (Full Article)
Learn how UnitedPros can help you with advanced vision and imaging systems for Biotechnology and Pharmaceuticals.
Technical Product and Service News and Insights